ArticleBMJ open2024

SIGNET: protocol for a multicentre, single-blind prospective, group sequential, randomised controlled trial to evaluate the benefits of a single dose of simvastatin given to potential organ donors declared dead by neurological criteria on outcomes in organ recipients.

Amy Evans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.